NEW BRUNSWICK, N.J., Jan. 23 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE:JNJ) today announced the completion of its previously announced acquisition of Mentor Corporation (NYSE:MNT), a leading supplier of medical products for the global aesthetic market. Mentor is expected to operate as a stand-alone business unit reporting through ETHICON, Inc., a Johnson & Johnson company and a leading provider of suture, mesh and other products for a wide range of surgical procedures.
According to Gary Pruden, Company Group Chairman, Johnson & Johnson, with responsibility for the ETHICON Franchise, "Mentor will become the cornerstone of a broader Johnson & Johnson strategy for aesthetic medicine -- serving both consumers and medical professionals. We will use our combined strengths and experience to build a market-leading aesthetic business that capitalizes on Johnson & Johnson's broad-based commercial capabilities, worldwide surgical care footprint, and clinical scientific capabilities." About Johnson & Johnson Caring for the world, one person at a time ... inspires and unites the people of Johnson & Johnson. We embrace research and science -- bringing innovative ideas, products and services to advance the health and well-being of people. Our 119,000 employees at more than 250 Johnson & Johnson companies work with partners in health care to touch the lives of over a billion people every day, throughout the world. DATASOURCE: Johnson & Johnson CONTACT: Press, Jeffrey J. Leebaw, +1-732-524-3350, or mobile, +1-732-642-6608, or Bill Price, +1-732-524-6623, or mobile, +1-732-668-3735, or Investor, Louise Mehrotra, +1-732-524-6491, or Stan Panasewicz, +1-732-524-2524 Web Site: http://www.jnj.com/
|